210 related articles for article (PubMed ID: 21231805)
1. Treatment of graft-versus-host-disease with mesenchymal stromal cells.
Kebriaei P; Robinson S
Cytotherapy; 2011 Mar; 13(3):262-8. PubMed ID: 21231805
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence.
Rizk M; Monaghan M; Shorr R; Kekre N; Bredeson CN; Allan DS
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1416-1423. PubMed ID: 27130504
[TBL] [Abstract][Full Text] [Related]
4. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
[TBL] [Abstract][Full Text] [Related]
5. Adult adherent stromal cells in the management of graft-versus-host disease.
Newell LF; Deans RJ; Maziarz RT
Expert Opin Biol Ther; 2014 Feb; 14(2):231-46. PubMed ID: 24397853
[TBL] [Abstract][Full Text] [Related]
6. [Mesenchymal stromal cells in the treatment of graft-versus-host disease: where do we stand?].
Schüle S; Berger A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1265-73. PubMed ID: 26369762
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.
Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Cho SJ; Ryu KH
Cytotherapy; 2010 May; 12(3):361-70. PubMed ID: 20078382
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells.
Dazzi F; Marelli-Berg FM
Eur J Immunol; 2008 Jun; 38(6):1479-82. PubMed ID: 18493977
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation.
Bernardo ME; Locatelli F
Methods Mol Biol; 2016; 1416():3-20. PubMed ID: 27236663
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells: a new tool against graft-versus-host disease?
Baron F; Storb R
Biol Blood Marrow Transplant; 2012 Jun; 18(6):822-40. PubMed ID: 21963621
[TBL] [Abstract][Full Text] [Related]
11. Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization.
Schepers K; Fibbe WE
Ann N Y Acad Sci; 2016 Apr; 1370(1):15-23. PubMed ID: 26713608
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease.
Kebriaei P; Robinson S
Front Oncol; 2011; 1():16. PubMed ID: 22655232
[TBL] [Abstract][Full Text] [Related]
13. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells for graft-versus-host disease.
Tolar J; Villeneuve P; Keating A
Hum Gene Ther; 2011 Mar; 22(3):257-62. PubMed ID: 21288086
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
[TBL] [Abstract][Full Text] [Related]
16. Remestemcel-L for the treatment of graft versus host disease.
Locatelli F; Algeri M; Trevisan V; Bertaina A
Expert Rev Clin Immunol; 2017 Jan; 13(1):43-56. PubMed ID: 27399600
[TBL] [Abstract][Full Text] [Related]
17. Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease.
Jang YK; Kim M; Lee YH; Oh W; Yang YS; Choi SJ
Cytotherapy; 2014 Mar; 16(3):298-308. PubMed ID: 24418403
[TBL] [Abstract][Full Text] [Related]
18. [Mesenchymal stem cells for treatment of graft-versus-host disease].
Najima Y
Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
[TBL] [Abstract][Full Text] [Related]
19. Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study.
Arima N; Nakamura F; Fukunaga A; Hirata H; Machida H; Kouno S; Ohgushi H
Cytotherapy; 2010 Apr; 12(2):265-8. PubMed ID: 19961282
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.
Blanco B; Herrero-Sánchez MD; Rodríguez-Serrano C; García-Martínez ML; Blanco JF; Muntión S; García-Arranz M; Sánchez-Guijo F; Del Cañizo C
Eur J Haematol; 2016 Dec; 97(6):528-537. PubMed ID: 27118602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
